University of Helsinki
VC Fund
Helsinki, Finland
University of Helsinki is a VC fund in Helsinki focused on Medical and Health Care. The University of Helsinki has the widest range of disciplines in Finland. It was established in Turku in 1640, but was transferred to Helsinki in 1828. The number of faculties is eleven. There are 35,000 degree students and 7,900 staff. The number of degrees taken each year is an average 5,000, of which about 470 are doctorates. The Universityconcentrates on high-level scientific research and researcher education. Scientific research is also the basis of the teaching provided by the University. The University operations support the development of society, as well as business and industry. University representatives offer their competencies for the benefit of society through a number of positions of trust and expertise. The results produced by the research and teaching carried out at the University have been widely acclaimed. The University participates in more than half of the national Centres of Excellence in Research, elected by international scientific panels. The University of Helsinki has been invited to be a member of the League of European Research Universities, a co-operation body for the leading European research universities. According to international expert panels, also the teaching provided by the University of Helsinki is of a high European level. The University has strong international connections. It has some 80 co-operation agreements with universities on different continents. The University researchers are in great demand as experts in international scientific communities, meetings and publications. The University is bilingual, but in addition to Finnish and Swedish teaching is also provided in English. Besides Helsinki, the University has operations at 20 localities throughout Finland.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 17%
Last updated:
For AI agents: llms.txt
Industries University of Helsinki invests in
Stages University of Helsinki invests in
Countries University of Helsinki invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
| See all 11 contacts → | |||
Round size
- Seed
- $54k–$7.4M
- Pre-Seed
- $837k–$1.2M
- Series A
- $2.9M–$34M
Investment Focus
Industry
- Medical 2 (17%)
- Health Care 2 (17%)
- Biotechnology 2 (17%)
- Health Diagnostics 2 (17%)
- Apps 1 (8%)
Stage
- Seed 5 (42%)
- Series A 3 (25%)
- Pre-Seed 2 (17%)
- Grant 1 (8%)
- Debt Financing 1 (8%)
Country
- Finland 8 (67%)
- Luxembourg 1 (8%)
- United States 1 (8%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Kustaa Piha
Researcher
|
Researcher | Total investments: 5 | Find email | |
Alejandro García Pérez
Principal Investigator
|
Principal Investigator | Total investments: 0 | Find email | |
Esko Kankuri
Principal Investigator and Head of Laboratory
|
Principal Investigator and Head of Laboratory | Total investments: 0 | Find email | |
Gonçalo Barreto
Postdoctoral Researcher
|
Postdoctoral Researcher | Total investments: 0 | Find email | |
Javier Reyes
University Lecturer
|
University Lecturer | Total investments: 0 | Find email | |
| See all 11 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Kasvu develops first and best-in-class small molecule neuroplastogens for diseases where neuronal connectivity is altered | $34.2M / Series A / Sep 24, 2026 | ||
| Ferrivia Oy is a Finnish health-tech startup specializes in digital health services and personalized tracking for iron deficiency and low ferritin levels. | $57.5K / Seed / Jun 17, 2026 | ||
| Avenue Biosciences is a transatlantic biotechnology company committed to speeding up the research and development of protein biologics and tools for the biotechnology industry, ensuring that no lifesaving therapy goes unmet due to production constraints. | $7.4M / Seed / Jan 12, 2026 | ||
| MultivisionDx's computer vision technology integrates the tumor's unique biological and geographical properties, as well as its milieu, to generate patient-specific tumor profiles. | $1.2M / Pre-Seed / Dec 02, 2025 | ||
| Perfat Technologies is a health-based technology company that develops fat-management applications based on healthy vegetable oils. | $2.9M / Series A / Sep 10, 2025 | ||
| Solid IO believes cancer care should be as precise and personal as possible. Solid IO’s tumor-on-chip platform is transforming oncology, delivering real-time, patient-specific insights that empower clinicians to make life-changing treatment decisions. With Solid IO, the next era of precision oncology | $836.9K / Pre-Seed / Feb 24, 2025 | ||
| Moncyte Health is developing a patented technology to optimize the treatment and prevention of cardiovascular disease. | Grant / Oct 08, 2024 | ||
| Moncyte Health is developing a patented technology to optimize the treatment and prevention of cardiovascular disease. | $1.1M / Seed / Oct 08, 2024 | ||
| The NADMED test was developed by one of the world's foremost experts on NAD metabolism in humans. NADMED's metabolite extraction system is the only method for measuring all four NADs and glutathione. | $3.9M / Series A / Aug 22, 2024 | ||
| Sustashift offers software solutions and advisory services for both listed and non-listed companies concerning Corporate Sustainability Reporting Directive compliance. They offer pre-made templates and digital markup for sustainability reports that is automatically generated. Additionally, they provide personalized audit templates and automatedXBRL tagging to facilitate compliance. | $54.3K / Seed / May 21, 2024 | ||
| See all 12 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does University of Helsinki invest in?
University of Helsinki invests primarily in Medical, Health Care and Biotechnology startups, most often at Seed and Series A stage. Most of the 12 investments tracked by Shizune back companies in Finland. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is University of Helsinki's check size?
University of Helsinki typically joins rounds of $54k–$7.4M at Seed, $837k–$1.2M at Pre-Seed and $2.9M–$34M at Series A. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds University of Helsinki participates in.
How do I contact University of Helsinki?
Public channels for University of Helsinki include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at University of Helsinki?
The team at University of Helsinki includes Kustaa Piha (Researcher), Alejandro García Pérez (Principal Investigator) and Esko Kankuri (Principal Investigator and Head of Laboratory), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
